Lecture 8: Enzymes for Therapeutic and Diagnostic Applications Flashcards
What are the main general clinical applications of enzymes?
- As therapeutics
- As key components in diagnostic/analytical assays
What are the concerns involving enzyme Replacement Therapy?
- Delivery to site of action → very poor oral bioavailability, so need to use invasive methods to administer the drug.
- Effectiveness of chronic enzyme replacement therapy may be reduced over time.
- Protein orthologue purified from an animal source may elicit immune response, nut the effectiveness has improved with recombinant enzymes
- Enzymes are easily degraded so they have a small half life.
What happens in Severe combined immunodeficiency disease (SCID)?
Impaired T and B cell function at birth
What are the 2 causes that lead to severe combined immunodeficiency disease (SCID)?
- Most common type: X-linked SCID; mutations in IL-2 receptor gamma subunit
- Second most common form (15% of SCID): adenosine deaminase (ADA) deficiency.
How does adenosine deaminase deficiency lead to severe combined immunodeficiency disease (SCID)?
- The deficiency stops the breakdown of adenosine and 2-deoxyadenosine
- Adenosine gets converted to dATP, so adenosine, dATP and 2-deoxyadenosine build up in the body
- 2 - deoxyadenosine is a cytotoxic metabolite and is generally considered the primary cause of lymphotoxicity.
- Elevated adenosine contributes to apoptosis and blocks the differentiation of thymocytes, causing severe T lymphopenia.
- The buildup of dATP, which induces the cell to make cytochrome c, destroys and signals for apoptosis in all rapidly proliferating cells. This includes cells in the GI tract, immune system lymphocytes, and sperm cells.
What is the drug used to treat severe combined immunodeficiency disease (SCID) and what is it
Adagen
It’s pegylated bovine adenosine deaminase (ADA)
What is the function of PEGylating drugs?
- PEG chains increase drug’s size, which prevents it from renal clearance and increases circulation half-life
- Increasing PEG linker length allows improved solubility and decreases accessibility for proteolytic enzymes and antibodies
- reduce degradation by proteases, lower binding by host antibodies and reduce immunogenicity.
What is the main side effect associated with the long term use of PEG-ADA?
The development of anti-ADA antibody which makes the drug ineffective.
What gene mutation causes cystic fibrosis?
- Various mutations a gene encoding for cystic fibrosis transmembrane conductance regulator (CFTR), a chloride channel.
- CFTR regulates components of sweat, digestive juices, and mucus.
What is the treatment given to patients with cystic fibrosis?
- Pulmozyme
- It is a recombinant human DNase I enzyme (produced in CHO cells) that selectively cleaves DNA and reduces viscosity of mucus.
- It is administered daily
What happens in Gaucher’s disease?
- It is caused by a deficiency in glucocerebrosidase enzyme (esp beta-glucosidase) that breaks down glycolipids called glucocerebroside
- Glucocerebroside builds up in the liver and spleen, causing enlargement and affecting their functions
What is the drug used to treat Gaucher’s disease and how does it work?
- Cerezyme
- It has imiglucerase which is modified placental glucocerebrosidase
- The glycosylation sites in imiglucerase terminate in mannose which allows them to enter macrophages and digest the glucoerebroside
What are the most commonly employed biological samples used in in vitro diagnostics?
- Enzymes: to detect and/or quantify various medically significant biomolecules or metabolites
- Antibodies: to detect
and/or quantify specific substances (antigens).
How should the Kcat and Km be for an enzyme used in diagnostic applications?
- High Kcat
- Low Km
What are the different diagnostic tests for diabetes?
- Urine glucose
- Blood glucose
- HbA1c testing